News
INMD
14.01
+0.25%
0.04
InMode Reshapes Leadership with New Chairman and CFO in May 2026
TipRanks · 14h ago
InMode Appoints Moshik Itzkovich As CFO, Shlomo Nass As Chairman
NASDAQ · 14h ago
InMode names Moshik Itzkovich as CFO, succeeding Yair Malca
TipRanks · 14h ago
InMode names Shlomo Nass board chairman
PUBT · 15h ago
INMODE APPOINTS DR. SHLOMO NASS AS CHAIRMAN OF THE BOARD AND MOSHIK ITZKOVICH AS CHIEF FINANCIAL OFFICER
Reuters · 15h ago
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
PR Newswire · 15h ago
Weekly Report: what happened at INMD last week (0511-0515)?
Weekly Report · 2d ago
Undervalued Small Caps With Insider Buying To Watch In May 2026
Simply Wall St · 6d ago
InMode to Present at Upcoming Investor Conferences and Events
PR Newswire · 05/13 12:30
Canaccord Genuity Sticks to Their Hold Rating for InMode (INMD)
TipRanks · 05/11 11:29
Weekly Report: what happened at INMD last week (0504-0508)?
Weekly Report · 05/11 10:13
InMode Is Maintained at Overweight by Barclays
Dow Jones · 05/07 16:39
InMode Price Target Cut to $19.00/Share From $21.00 by Barclays
Dow Jones · 05/07 16:39
Barclays Maintains Overweight on InMode, Lowers Price Target to $19
Benzinga · 05/07 16:29
InMode price target lowered to $14 from $17 at Baird
TipRanks · 05/07 15:55
InMode: Hold Rating Reiterated as Analyst Balances Improving Fundamentals with Governance Risks; $15 Price Target Maintained
TipRanks · 05/07 13:56
InMode price target lowered to $19 from $21 at Barclays
TipRanks · 05/07 11:59
InMode Is Maintained at Neutral by Baird
Dow Jones · 05/07 11:43
InMode Price Target Cut to $14.00/Share From $17.00 by Baird
Dow Jones · 05/07 11:43
Baird Maintains Neutral on InMode, Lowers Price Target to $14
Benzinga · 05/07 11:33
More
Webull provides a variety of real-time INMD stock news. You can receive the latest news about Inmode Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About INMD
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.